13,800 Shares in BWX Technologies, Inc. $BWXT Acquired by Barometer Capital Management Inc.

Barometer Capital Management Inc. acquired a new stake in shares of BWX Technologies, Inc. (NYSE:BWXT) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 13,800 shares of the technology company’s stock, valued at approximately $2,822,000. BWX Technologies comprises approximately 1.2% of Barometer Capital Management Inc.’s holdings, making the stock its 22nd biggest holding.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Aventura Private Wealth LLC purchased a new position in shares of BWX Technologies during the fourth quarter worth $29,000. MV Capital Management Inc. purchased a new stake in BWX Technologies during the fourth quarter worth $32,000. WFA of San Diego LLC acquired a new stake in shares of BWX Technologies during the 2nd quarter valued at about $29,000. Tucker Asset Management LLC acquired a new stake in BWX Technologies in the fourth quarter valued at approximately $36,000. Finally, ORG Partners LLC grew its stake in BWX Technologies by 143.2% in the 4th quarter. ORG Partners LLC now owns 231 shares of the technology company’s stock valued at $40,000 after acquiring an additional 136 shares during the period. Institutional investors and hedge funds own 94.39% of the company’s stock.

Analysts Set New Price Targets

BWXT has been the subject of several research reports. Truist Financial boosted their price objective on BWX Technologies from $205.00 to $212.00 and gave the stock a “hold” rating in a research note on Monday, May 11th. Bank of America boosted their target price on shares of BWX Technologies from $230.00 to $250.00 and gave the company a “buy” rating in a report on Wednesday, March 25th. Zacks Research cut BWX Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, May 11th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of BWX Technologies in a research note on Friday, May 22nd. Finally, Seaport Research Partners upgraded shares of BWX Technologies from a “neutral” rating to a “buy” rating and set a $245.00 price target for the company in a research report on Monday, June 22nd. Two analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $228.00.

Insider Activity at BWX Technologies

In other BWX Technologies news, CFO Michael Thomas Fitzgerald sold 2,417 shares of the firm’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $209.25, for a total value of $505,757.25. Following the completion of the transaction, the chief financial officer owned 6,884 shares of the company’s stock, valued at $1,440,477. This trade represents a 25.99% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CEO Rex D. Geveden sold 10,000 shares of the business’s stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $204.81, for a total transaction of $2,048,100.00. Following the completion of the transaction, the chief executive officer owned 202,491 shares of the company’s stock, valued at approximately $41,472,181.71. This trade represents a 4.71% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by corporate insiders.

BWX Technologies Stock Performance

Shares of BWX Technologies stock opened at $173.16 on Wednesday. The stock has a market capitalization of $15.86 billion, a price-to-earnings ratio of 46.30, a price-to-earnings-growth ratio of 2.89 and a beta of 0.74. The company has a debt-to-equity ratio of 1.58, a current ratio of 2.40 and a quick ratio of 2.33. The business has a 50-day moving average of $193.36 and a 200 day moving average of $202.97. BWX Technologies, Inc. has a 12 month low of $136.18 and a 12 month high of $241.82.

BWX Technologies (NYSE:BWXT) last issued its quarterly earnings results on Monday, May 4th. The technology company reported $1.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.92 by $0.20. The company had revenue of $860.22 million for the quarter, compared to analyst estimates of $837.47 million. BWX Technologies had a net margin of 10.20% and a return on equity of 31.33%. The business’s revenue for the quarter was up 26.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.91 earnings per share. BWX Technologies has set its FY 2026 guidance at 4.600-4.750 EPS. As a group, sell-side analysts forecast that BWX Technologies, Inc. will post 4.6 earnings per share for the current year.

BWX Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, June 5th. Investors of record on Tuesday, May 19th were issued a $0.27 dividend. The ex-dividend date was Tuesday, May 19th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.6%. BWX Technologies’s payout ratio is 28.88%.

About BWX Technologies

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.